Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: Case- control studies of Japanese Brazilians and non-Japanese Brazilians

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 7, 2000, Pages 675-680

  Nishimoto, Ines Nobuko ^a,b   Hanaoka, Tomoyuki ^a   Sugimura, Haruhiko ^c   Nagura, Kiyoko ^c   Ihara, Megumi ^c   Li, Xiao Jin ^c   Arai, Tomio ^c   Hamada, Gerson Shigeaki ^a,d   Kowalski, Luis P ^b   Tsugane, Shoichiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Hospital Santa Cruz   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORZOXAZONE; CYTOCHROME P450;

ADULT; ARTICLE; BRAZIL; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENDEMIC DISEASE; ENVIRONMENTAL FACTOR; FOOD INTAKE; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; OXIDATION; PRIORITY JOURNAL; STOMACH CANCER;

AGED; BRAZIL; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP2E1; DIET; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK ASSESSMENT; STOMACH NEOPLASMS;

EID: 18544408734     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Haenszel, W., Kurihara, M., Segi, M., and Lee, R. K. Stomach cancer among Japanese in Hawaii. J. Natl. Cancer Inst., 49: 969-988, 1972.
2. Tsubono, Y., Takahashi, T., Iwase, Y., Iitoi, Y., Akabane, M., and Tsugane, S. Nutrient consumption and gastric cancer mortality in five regions of Japan. Nutr. Cancer, 27: 310-315, 1997.
3. Kono, S., and Hirohata, T. Nutrition and stomach cancer. Cancer Causes Control, 7: 41-55, 1996.
4. Sugimura, H. Familial clustering of gastric cancer in Japan. In: M. Nishi, H. Sugano, and T. Takahashi (eds.), International Gastric Cancer Congress 1 Kyoto, pp. 219-223. Bologna, Italy: Monduzi Editore, 1995.
5. Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A., and Reeve, A. E. E-cadherin germline mutations in familial gastric cancer. Nature (Lond.), 392: 402-405, 1998.
6. Hartman, P. E. Review: putative mutagens and carcinogens in foods. I. Nitrate/nitrite ingestion and gastric cancer mortality. Environ. Mutagen., 5: 111-121, 1983.
7. Tannenbaum, S. R., and Correa, P. Nitrate and gastric cancer risks [letter]. Nature (Lond.), 317: 675-676, 1985.
8. Camus, A. M., Geneste, O., Honkakoski, P., Bereziat, J. C., Henderson, C. J., Wolf, C. R., Bartsch, H., and Lang, M. A. High variability of nitrosamine metabolism among individuals: role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans. Mol. Carcinog., 7: 268-275, 1993.
9. Mueller, R. L., Hagel, H. J., Wild, H., Ruppin, H., and Domschke, W. Nitrate and nitrite in normal gastric juice. Precursors of the endogenous N-nitroso compound synthesis. Oncology, 43: 50-53, 1986.
10. Dikun, P. P., Ermilov, V. B., and Shendrikova, I. A. Some approaches to prevention of endogenous formation of N-nitrosamines in humans, IARC Scientific Publ., pp. 552-557. Lyon, France: IARC, 1991.
11. Nitrate and human cancer [editorial], Lancet, 2: 281-282, 1977.
12. Kato, S., Shields, P. G., Caporaso, N. E., Hoover, R. N., Trump, B. F., Sugimura, H., Weston, A., and Harris, C. C. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res., 52: 6712-6715, 1992.
13. Tsugane, S., de Souza, J. M., Costa, M. L., Jr., Mirra, A. P., Gotlieb, S. L., Laurenti, R., and Watanabe, S. Cancer incidence rates among Japanese immigrants in the city of Sao Paulo, Brazil, 1969-78. Cancer Causes Control, 1: 189-193, 1990.
14. Tsugane, S., Gotlieb, S. L., Laurenti, R., de Souza, J. M., and Watanabe, S. Cancer mortality among Japanese residents of the city of Sao Paulo, Brazil. Int. J. Cancer, 45: 436-439, 1990.
15. Kato, S., Shields, P. G., Caporaso, N. E., Sugimura, H., Trivers, G. E., Tucker, M. A., Trump, B. F., Weston, A., and Harris, C. C. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Cancer Epidemiol. Biomark. Prev., 3: 515-518, 1994.
16. Hamada, G. S., Sugimura, H., Suzuki, I., Nagura, K., Kiyokawa, E., Iwase, T., Tanaka, M., Takahashi, T., Watanabe, S., Kino, I., and Tsugane, S. The heme-binding region polymorphism of cytochrome P4501A1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro. Cancer Epidemiol. Biomark. Prev., 4: 63-67, 1995.
17. Blomeke, B., Bennett, W. P., Harris, C. C., and Shields, P. G. Serum, plasma and paraffin-embedded tissues as sources of DNA for studying cancer susceptibility genes. Carcinogenesis (Lond.), 18: 1271-1275, 1997.
18. Armitage, P., and Berry, G. Goodness of fit of frequency distributions. In: Statistical Methods in Medical Research. Oxford: Blackwell Science Ltd, 1994.
19. Franco, E., Kowalski, L., Oliveira, B., Curado, M., Pereira, R., Silva, M., Fava, A., and Torloni, H. Risk factors for oral cancer in Brazil: a case-control study. Int. J. Cancer, 43: 992-1000, 1989.
20. Japanese Research Society for Gastric Cancer, Edt. Japanese Classification of Gastric Carcinoma. Tokyo: Kanehara, 1995.
21. Lauren, P. The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma. An attempt at a histological classification. Acta Pathol. Microbiol. Scand., 64: 31-39, 1965.
22. Guengerich, F. P., Kim, D. H., and Iwasaki, M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol., 4: 168-179, 1991.
23. Yang, C., and Smith, T. Mechanisms of nitrosamine bioactivation and carcinogenesis. Adv. Exp. Med. Biol., 387: 385-394, 1996.
24. Yang, M., Yamamura, K., Yan, Y., Fukamachi, Y., Hirano, T., Kawamoto, T., and Higashi, K. Studies on the microsomal cytochrome P450s in the livers of carcinogen-resistant and sensitive rats during long-term administration of 3′-methyl-4-dimethylaminoazobenzene [published erratum: J. UOEH 20: 79, 1998], J. UOEH, 19: 277-286, 1997.
25. Hecht, S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol., 11: 559-603, 1998.
26. Watanabe, J., Hayashi, S., and Kawajiri, K. Different regulation and expression of the human CYP2E1 gene due to the Rsal polymorphism in the 5′-flanking region. J. Biochem. (Tokyo), 116: 321-326, 1994.
27. Hayashi, S., Watanabe, J., and Kawajiri, K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. (Tokyo), 110: 559-565, 1991.
28. Uematsu, F., Ikawa, S., Kikuchi, H., Sagami, I., Kanamaru, R., Abe, T., Satoh, K., Motomiya, M., and Watanabe, M. Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenetics, 4: 58-63, 1994.
29. Wu, X., Amos, C. I., Kemp, B. L., Shi, H., Jiang, H., Wan, Y., and Spitz, M. R. Cytochrome P450 2E1 Oral polymorphisms in lung cancer in minority populations. Cancer Epidemiol. Biomark. Prev., 7: 13-18, 1998.
30. Watanabe, J., Yang, J. P., Eguchi, H., Hayashi, S., Imai, K., Nakachi, K., and Kawajiri, K. An Rsa I polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population. Jpn. J. Cancer Res., 86: 245-248, 1995.
31. Ikawa, S., Uematsu, F., Watanabe, K., Kimpara, T., Osada, M., Hossain, A., Sagami, I., Kikuchi, H., and Watanabe, M. Assessment of cancer susceptibility in humans by use of genetic polymorphisms in carcinogen metabolism. Pharmacogenetics, 5 (Suppl.): S154-S160, 1995.
32. Hirvonen, A., Husgafvel-Pursiainen, K., Anttila, S., Karjalainen, A., and Vainio, H. The human CYP2E1 gene and lung cancer: Dral and Rsal restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis (Lond.), 14: 85-88, 1993.
33. Morita, S., Yano, M., Shiozaki, H., Tsujinaka, T., Ebisui, C., Morimoto, T., Kishibuti, M., Fujita, J., Ogawa, A., Taniguchi, M., Inoue, M., Tamura, S., Yamazaki, K., Kikkawa, N., Mizunoya, S., and Monden, M. CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamouscell carcinoma of the esophagus. Int. J. Cancer, 71: 192-195, 1997.
34. Kato, S., Onda, M., Matsukura, N., Tokunaga, A., Tajiri, T., Kim, D. Y., Tsuruta, H., Matsuda, N., Yamashita, K., and Shields, P. G. Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control study of gastric cancer and liver disease. Pharmacogenetics, 5 (Suppl.): S141-S144, 1995.
35. Hung, H. C., Chuang, J., Chien, Y. C., Chern, H. D., Chiang, C. P., Kuo, Y. S., Hildesheim, A., and Chen, C. J. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol. Biomark. Prev., 6: 901-905, 1997.
36. Lin, D. X., Tang, Y. M., Peng, Q., Lu, S. X., Ambrosone, C. B., and Kadlubar, F. F. Susceptibility to esophageal cancer and genetic polymorphism in glutathione S-transferases T1, P1, and M1 and Cytochrome P450 2E1. Cancer Epidemiol. Biomark. Prev., 7: 1013-1018, 1998.
37. Lucas, D., Menez, J. F., and Berthou, F. Chlorzoxazone: an in vitro and in vim substrate probe for liver CYP2E1. Methods Enzymol., 272: 115-123, 1996.
38. Le Marehand, L., Sivaraman, L., Pierce, L., Seifried, A., Lum, A., Wilkens, L. R., and Lau, A. F. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res., 58: 4858-4863, 1998.
39. Xiang, Y. Y., Wang, D. Y., Tanaka, M., Igarashi, H., Kamo, T., Shen, Q., Sugimura, H., and Kino, 1. Efficient and specific induction of esophageal tumors in rats by precursors of N-nitrososarcosine ethyl ester. Pathol. Int., 45: 415-421, 1995.
40. Wang, D. Y., Xiang, Y. Y., Tanaka, M., Li, X. R., Li, J. L., Shen, Q., Sugimura, H., and Kino, I. High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis [published erratum, Cancer (Phila.) 75: 1404, 1995]. Cancer (Phila.), 74: 3089-3096, 1994.
41. Kato, S., Onda, M., Matsukura, N., Tokunaga, A., Matsuda, N., Yamashita, K., and Shields, P. G. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study. Cancer (Phila.), 77: 1654-1661, 1996.
42. Lauren, P. A., and Nevalainen, T. J. Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high-and low-risk areas. Cancer (Phila.), 71: 2926-2933, 1993.
43. Zheng, W., Deitz, A. C., Campbell, D. R., Wen, W. Q., Cerhan, J. R., Sellers, T. A., Folsom, A. R., and Hein, D. W. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 8: 233-239, 1999.
44. Marehand, L. L., Wilkinson, G. R., and Wilkens, L. R. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using Chlorzoxazone. Cancer Epidemiol. Biomark. Prev., 8: 495-500, 1999.